Form S-3 Spyre Therapeutics, Inc.

Go back to Form S-3 Spyre Therapeutics, Inc.

Spyre Therapeutics (SYRE) files mixed shelf

February 19, 2026 4:35 PM EST

Spyre Therapeutics (NASDAQ: SYRE) has filed mixed shelf of:
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
UNITS

... More